Declaración de accesibilidad Saltar la navegación
  • Volver a los sitios globales
  • +44 (0)20 7454 5110
  • GDPR
  • Periodistas
  • Solicitar más información
PR Newswire: news distribution, targeting and monitoring
  • Noticias
  • Productos
  • Contacto
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Solicitar más información
    • Teléfono

    • +44 (0)20 7454 5110 de 8 AM - 5 PM GMT

    • Contáctenos
    • Contáctenos

      +44 (0)20 7454 5110
      de 8 AM - 5 PM GMT

  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR

Mediso acquires nuclear medicine supplier Bartec Technologies
  • Deutschland - Deutsch
  • France - Français
  • Italia - Italiano
  • España - español
  • USA - English


Noticias proporcionadas por

Mediso

04 may, 2022, 07:41 GMT

Compartir este artículo

Share toX

Compartir este artículo

Share toX

FARNBOROUGH, England, and BUDAPEST, Hungary, May 4, 2022 /PRNewswire/ -- Mediso Ltd today announced the acquisition of Bartec Technologies Ltd, UK based company specialised in the supply, installation and support of Nuclear Medicine and Molecular Imaging equipment and accessories. The acquisition strengthens Mediso's market position in the UK and Ireland. Financial details of the acquisition were not disclosed.

Mediso Medical Imaging Systems with headquarters in Budapest is a dynamic supplier of Nuclear Medicine and modern Hybrid Imaging equipment to the health care and medical research institutions of the world.

In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership. With a thirty years history supplying and servicing for the human health, veterinary and research sectors, Bartec offers unique experience and expertise in the medical imaging industry.

Mediso has taken the step of having direct subsidiaries in USA, Germany, Australia and Poland. Following this pattern Mediso has negotiated to acquire Bartec from the LabLogic Group.

István Bagaméry, Managing Director of Mediso commented, "UK has always been considered as one of the most important markets for Mediso both in clinical and preclinical business. We have successfully developed and maintained a significant install base in close collaboration with Bartec over the past two decades. The acquisition of Bartec strengthens our local presence allowing us to build even closer relationships with our existing and prospective customers and sets path to establish new synergistic, strategic alliances with our key partners in the region."

Some product lines formerly handled by Bartec will transfer to Southern Scientific, a company in the LabLogic group to allow Bartec to concentrate more on Mediso applications, sales and support while continuing the core business operation. John Clapham, Chairman of LabLogic and MD of Bartec commented, "I have greatly enjoyed working in Bartec, they are a great team who look after customers very well. A direct link to the manufacturer, however, will allow the company to go from strength to strength; as LabLogic has found with its subsidiary in France."

Bartec will remain a trusted supplier of NMI products with its experienced operational team within Mediso group, and Bartec customers can continue communications through existing channels. The company will also focus on facilitation of building and maintaining strategic partnerships with key collaboration partners in the region.

Logo - https://mma.prnewswire.com/media/1806098/Mediso_Logo.jpg

SOURCE Mediso

Modal title

También de esta fuente

Mediso instala el auténtico sistema teranóstico TheraMAX SPECT/CT en el Hospital Universitario de Heidelberg

Mediso instala el auténtico sistema teranóstico TheraMAX SPECT/CT en el Hospital Universitario de Heidelberg

Mediso completa la instalación de un AnyScan® TRIO-TheraMAX SPECT/CT en el Departamento de Medicina Nuclear del Hospital Universitario de Heidelberg. ...

Más comunicados de prensa de esta fuente

Explorar

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Comunicados de prensa sobre temas similares

Contacte con PR Newswire

  • +44 (0)20 7454 5110
    de 8 AM - 5 PM GMT

Sitios globales

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brasil
  • Canada
  • Checo
  • Dinamarca
  • Finlandia
  • Francia
  • Alemania

 

  • India
  • Indonesia
  • Israel
  • Italia
  • México
  • Medio Oriente
  • Middle East - Arabic
  • Países Bajos
  • Noruega
  • Polonia

 

  • Portugal
  • Rusia
  • Eslovaquia
  • España
  • Suecia
  • Reino Unido
  • Estados Unidos

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contacte con PR Newswire

Sitios globales
  • Asia
  • Brasil
  • Canada
  • Checo
  • Dinamarca
  • Finlandia
  • Francia
  • Alemania
  • India
  • Israel
  • Italia
  • México
  • Medio Oriente
  • Países Bajos
  • Noruega
  • Polonia
  • Portugal
  • Rusia
  • Eslovaquia
  • España
  • Suecia
  • Reino Unido
  • Estados Unidos
+44 (0)20 7454 5110
de 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.